Terumo Corporation (TYO:4543)

Terumo Revenue

Terumo had revenue of 311.81B JPY in the quarter ending June 30, 2026, with 19.94% growth. This brings the company's total for the last twelve months to 1.18T, up 14.05% year-over-year. In the fiscal year ending March 31, 2026, Terumo had annual revenue of 1.13T with 9.24% growth. That makes Terumo the 1,901st largest company in the world by revenue and 183rd in Japan.

• Revenue (ttm): 1.18T
• Revenue Growth: +14.05%
• P/S Ratio: 2.94
• Revenue / Employee: 38.70M
• Employees: 30,591
• Market Cap: 3.50T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Cardiac and Vascular Company 676.42B 59.8%
• Blood and Cell Technologies Company 231.04B 20.4%
• Medical Care Solutions Company 216.14B 19.1%
• Terumo Organ Technologies 7.99B 0.7%
• Adjustments 294.00M 0.0%

By Geography

Chart

• Americas 443.41B 39.2%
• Europe 242.66B 21.4%
• Japan 222.60B 19.7%
• Asia and Others 131.90B 11.7%
• China 91.31B 8.1%

Fiscal year ended Mar 31, 2026 See the full Terumo breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.13T	95.71B	9.24%
Mar 31, 2025	1.04T	114.31B	12.40%
Mar 31, 2024	921.86B	101.65B	12.39%
Mar 31, 2023	820.21B	116.91B	16.62%
Mar 31, 2022	703.30B	89.46B	14.57%

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error